Navigation Links
PRA International Hosts an Infectious Diseases Audio Conference
Date:12/9/2009

RALEIGH, N.C., Dec. 9 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Scientific Head of Infectious Diseases Carl Kraus, M.D., Vice President of Scientific Affairs will host an audio conference along with John Powers, M.D., Assistant Professor of Medicine at George Washington University, on the design and regulatory environment considerations in anti-infective drug development.

Understanding the current regulatory environment and how it will affect the study design in anti-infective drug development is critical to addressing the present concerns of disease due to drug-resistant pathogens, biothreat agents, and novel influenza strains. The need to develop drugs with acceptable risk-benefit profiles for emerging and re-emerging diseases is evident. During the presentation, Drs. Kraus and Powers will review some of the basic principles surrounding anti-infective drug development in the framework of regulatory submissions as well as provide an update on some of the most important changes in recent years related to specific anti-infective indications. A question and answer discussion on selected infectious disease indications will follow their talk.

Both Drs. Powers and Kraus were formerly with the US Food and Drug Administration. At the FDA, Dr. Powers was the lead medical officer for Antimicrobial Drug Development and Resistance Initiatives, and Dr. Kraus was a medical officer in the Division of Special Pathogens and Immunologic Drug Products. Over the years, Dr. Powers has been involved in more than 50 clinical trials as a clinical investigator, has won several teaching awards, and has published extensively in the infectious disease field. Dr. Kraus has participated in more than 20 developmental programs for antiviral, antibiotic and biothreat agents and currently heads the Infectious Diseases Research Center (IDRC) at PRA.

PRA's IDRC is a cross-function
'/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
2. Reportlinker Adds Chiral Technology - International Technology & Market Trends
3. Swissray International Announces New Ownership
4. Chindex International to Present at Piper Jaffray Health Care Conference
5. SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts
6. International Operation Combats Online Supply of Counterfeit and Illegal Medicines
7. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
8. Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
9. 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name
10. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
11. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
(Date:9/19/2014)... Sept. 19, 2014  PCI is pleased to ... Biotec is a leading provider of Clinical Trial ... Bridgend, Wales in the ... significantly expands PCI,s presence in the UK/EU to ... adding packaging, storage and distribution capacity, as well ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/21/2014)... 21, 2014 Originally approved by ... GSK’s Flovent (fluticasone propionate) is a synthetic ICS ... for the maintenance treatment of asthma prophylactically in ... two formulations, Diskus and HFA, which received the ... active ingredient, fluticasone propionate, can bind to glucocorticoid ...
(Date:9/21/2014)... 2014 To accommodate the ever-growing customer ... provide more trendy items. Recently, the company has unveiled ... the new and elegant wedding gowns, Angeldress.co.uk wants to ... need in an easy way. Its high quality vintage ... from 12% off to 62% off. , Online shopping ...
(Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... ( http://www.thegranuflolawsuit.com/ ) have been added over the ... involving claims that allege serious cardiovascular injuries caused ... , A Case List updated on September 15th ... underway in the U.S. District Court, District of ...
(Date:9/21/2014)... “Cluster headaches are sometimes called ‘Suicide Headaches’ because ... said Steve Young of Ew Publishing; “I’ve had cluster ... is more intense.” , “It should be a relief ... that medical research is pointing to some relief and ... Serotonin (5-HT, 5-hydroxytryptamine) is a ubiquitous biochemical found in ...
(Date:9/21/2014)... Developers and plugin specialist of Final ... transition plugin entitled Transpack Vol. 3 from Pixel Film ... that will add a level of professionalism to any ... Film Studios. “Blurring the line between professional and armature, ... Transpack Vol. 3 returns with over 85 all new ...
Breaking Medicine News(10 mins):Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2
... benefit from liver supportive liver therapy while ... to enable bridging to liver transplantation. Albumin ... and renal function as well as the ... hemodynamic alterations in stable patients with cirrhosis ...
... Digestive Disease Week (DDW), SAN DIEGO, May ... Disease Week meeting that showed Cimzia(R) (certolizumab pegol),provided ... than 60 percent,of Crohn,s disease patients who were ... percent of patients achieved remission by six weeks.,Data ...
... Depression is a serious,but treatable health condition that ... be the focus of a national campaign during Mental,Health ... is,supported by the Anthem Blue Cross Foundation, the charitable ... Depression National Awareness Campaign is an effort to,increase knowledge, ...
... to introduce local physicians to new facility, SAN CARLOS, ... of its newest facility in San Carlos, welcoming doctors,located within ... was on hand to mingle with guests and provide tours ... were in attendance to learn about,SleepQuest,s services and the benefits ...
... Ltd. (Amex: CPD ) announced that the ... fiscal year 2008 ended March 31, 2008,prior to ... Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops,manufactures, markets ... largest wholesalers, distributors,drugstore chains and managed care providers., ...
... find tissue that normally lines the stomach in locations outside ... identified in such diverse locations as the scrotum, the gall ... a team led by Dr. Steven Paul Schmidt, is described ... of Gastroenterology. , Typically, when this gastric tissue is located ...
Cached Medicine News:Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 2Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 3Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 4Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 5Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 6Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 7Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 8Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 2Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 3Health News:SleepQuest Holds Open House 2Health News:Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008 2Health News:Heterotopic gastric tissue simulating acute appendicitis 2
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
... Urine Control contains a comprehensive ... that monitor tests for general ... hormones. It also contains hCG ... microalbumin at levels suitable for ...
qUAntify Control is designed to monitor the performance of urine dipstick testing. The control is available in 12 mL ready-to-use dropper bottles....
Medicine Products: